Publications by authors named "R Wahid"

Claim this Profile
I
Immunogenicity and safety of a SARS-CoV-2 N-terminal domain and receptor-binding domain monovalent XBB.1.5 vaccine in Japanese participants.
Christina M Grassi, Jing Feng, Rahnuma Wahid, Boris Kandinov, Saurabh Goel

Vaccine· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A combination typhoid and non-typhoidal Salmonella polysaccharide conjugate vaccine in healthy adults: a randomized, placebo-controlled phase 1 trial.
Wilbur H Chen, Robin S Barnes, Michael J Sikorski, Reva Datar, Roohali Sukhavasi, Rezwanul Wahid

Nat Med· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy, immunogenicity, and safety of a next-generation mRNA-1283 COVID-19 vaccine compared with the mRNA-1273 vaccine (NextCOVE): results from a phase 3, randomised, observer-blind, active-controlled trial.
Spyros Chalkias, Patrick Dennis, Dena Petersen, Krishnakumar Radhakrishnan, Leroy Vaughan, Rahnuma Wahid

Lancet Infect Dis· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and immunogenicity of a recombinant double-mutant heat-labile toxin derived from enterotoxigenic in healthy Bangladeshi adults delivered by three different routes.
Taufiqur Rahman Bhuiyan, Farhana Khanam, Salima Raiyan Basher, Pinki Dash, Mohiul Islam Chowdhury, Rezwanul Wahid

Front Bacteriol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase 1 randomized, placebo-controlled trial of a combination typhoid and non-typhoidal polysaccharide conjugate vaccine.
Wilbur H Chen, Robin S Barnes, Michael J Sikorski, Reva Datar, Roohali Sukhavasi, Rezwanul Wahid

medRxiv· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis